Does the addition of a second antipsychotic drug improve clozapine treatment?

Does the addition of a second antipsychotic drug improve clozapine treatment?

In patients with schizophrenia who do not have an optimal response to clozapine, it remains unclear if there is an evidence base to support a second antipsychotic in combination with clozapine. The present systematic review was therefore carried out to determine the efficacy of various clozapine com...

Bibliografiset tiedot
Päätekijät:	Barbui, C, Signoretti, A, Mulè, S, Boso, M, Cipriani, A
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2009

Samankaltaisia teoksia

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
Tekijä: Cipriani, A, et al.
Julkaistu: (2009)

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia
Tekijä: Barber, S, et al.
Julkaistu: (2017)

Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
Tekijä: Magdalena Jiménez-Cornejo, et al.
Julkaistu: (2016-12-01)

Combination treatment with second generation antipsychotics other than clozapine
Tekijä: C. Schmidt-Kraepelin
Julkaistu: (2021-04-01)

Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy.
Tekijä: Andretta, M, et al.
Julkaistu: (2005)

Leukopenia and agranulocytosis in atypical antipsychotic treatment - besides clozapine
Tekijä: B. Jorge, et al.
Julkaistu: (2021-04-01)

Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review.
Tekijä: Mazzucco, S, et al.
Julkaistu: (2008)

The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
Tekijä: Hülya Ertekin, et al.
Julkaistu: (2016-08-01)

Conventional vs. atypical antipsychotic medications.
Tekijä: Barbui, C, et al.
Julkaistu: (2006)

Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies.
Tekijä: Barbui, C, et al.
Julkaistu: (2014)

Clozapine: A special case of an atypical antipsychotic
Tekijä: Elina Marinho
Julkaistu: (2024-04-01)

Manipulation of Lipid Nanocapsules as an Efficient Intranasal Platform for Brain Deposition of Clozapine as an Antipsychotic Drug
Tekijä: Ahmed A. Katamesh, et al.
Julkaistu: (2024-11-01)

Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
Tekijä: Abbie G. Anderson, et al.
Julkaistu: (2019-05-01)

Antipsychotic polypharmacy in clozapine resistant schizophrenia: a randomized controlled trial of tapering antipsychotic co-treatment
Tekijä: Jari Tiihonen, et al.
Julkaistu: (2012-01-01)

A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine.
Tekijä: Davies, L, et al.
Julkaistu: (2008)

Clozapine-Induced Phototoxicity: An Unusual Side Effect of Atypical Antipsychotics
Tekijä: S. Al-Aojan, et al.
Julkaistu: (2018-01-01)

Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation.
Tekijä: Howes, O, et al.
Julkaistu: (2012)

Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
Tekijä: Cipriani, A, et al.
Julkaistu: (2013)

Retrospective evaluation of sociodemographic and clinical characteristics of patients with schizophrenia receiving clozapine monotherapy and clozapine combined with different antipsychotics
Tekijä: E. Yıldız, et al.
Julkaistu: (2024-04-01)

Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia
Tekijä: Júlio César Menezes Vieira, et al.
Julkaistu: (2024-06-01)

Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey.
Tekijä: Barbui, C, et al.
Julkaistu: (2013)

Augmentation of Antipsychotic Medications with Low-Dose Clozapine in Treatment-Resistant Schizophrenia—Case Reports and Discussion
Tekijä: Zoe Harrison, et al.
Julkaistu: (2021-01-01)

Differentiating probable nitrofurantoin-induced drug fever from antipsychotic-induced hyperthermia in a patient receiving clozapine
Tekijä: Stephen B. Vickery, PharmD, BCPS, et al.
Julkaistu: (2022-06-01)

Environmentally-relevant concentrations of the antipsychotic drugs sulpiride and clozapine induce abnormal dopamine and serotonin signaling in zebrafish brain
Tekijä: Bo Zhang, et al.
Julkaistu: (2022-10-01)

Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
Tekijä: Barbui, C, et al.
Julkaistu: (2011)

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
Tekijä: Leucht, S, et al.
Julkaistu: (2013)

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis
Tekijä: Leucht, S, et al.
Julkaistu: (2013)

Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach.
Tekijä: Veronese, A, et al.
Julkaistu: (2008)

Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials
Tekijä: Georgia Salanti, et al.
Julkaistu: (2023-02-01)

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Tekijä: Lewis, S, et al.
Julkaistu: (2006)

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
Tekijä: Lewis, S, et al.
Julkaistu: (2006)

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
Tekijä: S Lewis, et al.
Julkaistu: (2006-05-01)

Efficacy of antipsychotic drugs for schizophrenia - Authors' reply.
Tekijä: Leucht, S, et al.
Julkaistu: (2013)

Metabolic Side Effects from Antipsychotic Treatment with Clozapine Linked to Aryl Hydrocarbon Receptor (AhR) Activation
Tekijä: Karin Fehsel
Julkaistu: (2024-10-01)

CLEAR – clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings
Tekijä: C. Casetta, et al.
Julkaistu: (2024-02-01)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
Tekijä: Olga Płaza, et al.
Julkaistu: (2022-12-01)

Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs
Tekijä: Barbui Corrado, et al.
Julkaistu: (2011-09-01)

Does mental health staffing level affect antipsychotic prescribing? Analysis of Italian national statistics.
Tekijä: Fabrizio Starace, et al.
Julkaistu: (2018-01-01)

Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia.
Tekijä: Nosè, M, et al.
Julkaistu: (2009)

Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials.
Tekijä: Wei Zheng, et al.
Julkaistu: (2016-01-01)